Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

Authors

Andrew Hill, University of Liverpool
Dzintars Gotham, Imperial College London
Joseph Fortunak, Howard University
Jonathan Meldrum, University College London
Isabelle Erbacher, Imperial College London
Manuel Martin, Imperial College London
Haitham Shoman, Imperial College London
Jacob Levi, Imperial College London
William G. Powderly, Washington University School of Medicine in St. Louis
Mark Bower, Chelsea & Westminster Hospital

Journal

BMJ Open

Publication Date

2016

Volume

6

Issue

1

Inclusive Pages

e009586

Document Type

Open Access Publication

DOI

10.1136/bmjopen-2015-009586

Rights and Permissions

Hill A, Gotham D, Fortunak J, et al. Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment. BMJ Open 2016;6:e009586. doi:10.1136/bmjopen-2015-009586 This article was published in BMJ Open following peer review and can also be viewed on the journal’s website at http://bmjopen.bmj.com.”

Recommended Citation

Hill, Andrew; Gotham, Dzintars; Fortunak, Joseph; Meldrum, Jonathan; Erbacher, Isabelle; Martin, Manuel; Shoman, Haitham; Levi, Jacob; Powderly, William G.; and Bower, Mark, "Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment." BMJ Open. 6, 1. e009586. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/4608